Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 33 - Medicinal preparations containing inorganic active ingredients
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
05/2003
05/29/2003US20030099720 Pre-coital and post-coital rinse with anti-viral and skin-protective zinc salts
05/29/2003US20030099719 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
05/29/2003US20030099718 Nanocrystalline antimicrobial metals (noble metals)formed with atomic disorder are capable of releasing highly active clusters of the antimicrobial metal sufficient to cause microbiocidal effect; anti-inflammatory activity
05/29/2003US20030099716 Botanical and non-botanical ingredients for symptomatic relief of sexually transmitted diseases and other urogenital disorders
05/29/2003US20030099678 Method and topical formulation for treating skin conditions associated with aging
05/29/2003US20030099606 Iodinating an strong base anion exchange resin with iodine or an iodine compound; abosorbing through the pores of ion exchange resin
05/28/2003EP1313800A2 Antimicrobial adhesive latexes, methods of making thereof, and carpet articles containing same
05/28/2003EP1313762A2 Suppressor gene
05/28/2003EP1313574A1 Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same
05/28/2003EP1313514A2 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
05/28/2003EP1313488A1 Compositions and methods for improving cardiovascular function
05/28/2003EP1313475A1 Anti-cancer composition composed of anti-cancer and anti-malarial drugs
05/28/2003EP1313465A1 Composition and method for treatment of hypertriglyceridemia
05/28/2003EP1313460A2 Therapeutic use and formulation of (-)-tramadol
05/28/2003EP1313422A1 Non-hormonal vaginal contraceptive
05/28/2003EP1175149B9 Disinfecting composition based on h2o2, acids and metal ions
05/28/2003EP1140035B1 Method for preparing an effervescent granulate comprising iron gluconate, granulate thus obtained and tablets containing the same
05/28/2003EP0939641B1 Topical products as prophylactic or curative agents for bacterial skin infections
05/28/2003CN1420770A Method of delivery of cetyl myristoleate
05/28/2003CN1419919A 'Acne and rosacca aqueous powder' and 'acne and rosacca capsule' as medicine for treating acne and rosacca
05/28/2003CN1109555C Medicine for treating fracture and traumatic injury, and preparing method thereof
05/28/2003CN1109553C Chinese medicine capsule for treating diabetes
05/28/2003CN1109552C Enteritis curing capsule
05/28/2003CN1109550C Plaster for dispelling wind-evil and wetness-evil and stopping pain
05/28/2003CN1109542C Improved nicotine lozenge and therapeutic method for smoking cessation
05/27/2003US6569857 Increasing the possibility of conception while enhancing nutritional stores for a developing embryo or fetus prior to or during pregnancy by administering 20-125 mg per 55kg of body weight of a vitamin 6 and 1-3mg per 55kg of a folic acid
05/22/2003WO2003042404A2 Breast cancer eradication program
05/22/2003WO2003042344A2 Apo2 ligand/trail formulations
05/22/2003WO2003042098A1 Granular zirconium phosphate and methods for synthesis of same
05/22/2003WO2003041703A2 Use of a flavonoid for the treatment of burns
05/22/2003WO2003041701A2 Preparation for improving the action of receptors
05/22/2003WO2003041681A2 Lipid carrier compositions with enhanced blood stability
05/22/2003WO2003041680A1 Topical compositions containing enzymes stabilized with inhibitors
05/22/2003WO2003041645A2 Method of vaccinating a human patient to prevent metastatic tumors
05/22/2003WO2003000299B1 Laxative preparation
05/22/2003WO2002076403A3 Methods for the treatment of hiv and other viruses
05/22/2003WO2002056912A3 Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
05/22/2003US20030096861 Producing an aqueous solution of bismuth sodium tartrate; extracting a magma of bismuth sodium tartrate from aqueous solution and dissolving magma into a salting-in mixture to form semitransparent colloidal solution
05/22/2003US20030096794 Compositions and kits comprising a defined boron compound, methods of their preparation, and use and administration thereof
05/22/2003US20030096741 Enhanced mineral delivery
05/22/2003US20030095950 Trace minerals solution containing organic mineral elements; an Acidophilus sp. innoculum; vitamin A, vitamin D, and folic acid; cobalt amino acid chelates; and dried kelp,
05/22/2003US20030095932 Oxidative fluorinator compounds as antimicrobials
05/21/2003EP1312369A1 Cardiac arrest fluid
05/21/2003EP1312362A1 Method for the suppression of visceral pain by regulating T-type calcium channel
05/21/2003EP1311291A2 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists
05/21/2003EP1311241A2 Use of a porous carrier
05/21/2003EP1142578B1 Method for producing an antitumoral agent and antitumoral agent thus obtained
05/21/2003EP0797442B1 Treatment of optic neuritis
05/21/2003CN1419453A Pharmaceutical gel composition
05/21/2003CN1418648A Medicine for treating hepatitis
05/21/2003CN1418640A Exterior use prepn. for treating skin trauma
05/21/2003CN1418616A Cosmtics treatment using novel retinoid
05/20/2003US6566402 Trisodium citrate
05/20/2003US6566382 Stabilized isothiazolone-containing compositions
05/20/2003US6565896 Cholesterol treatment formulation
05/20/2003US6565895 Side-effect reduction of anti-cancer therapy
05/20/2003US6565890 Inorganic reaction product containing tungsten and vanadium oxide
05/20/2003US6565887 Magnetic heating efficiency, alternating frequency; antitumor, anticarcinogenic agents
05/20/2003US6565866 Iodophor compositions
05/15/2003WO2003040351A1 A novel non-antibiotic strategy against ogip infections based on an activated cereal product or ferric quinate
05/15/2003WO2003039793A1 Preparation of metallic nanoparticle with shell-crosslinked micelle as mold
05/15/2003WO2003039572A1 Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
05/15/2003WO2003039571A1 Improved use of antitumoral compound in cancer therapy
05/15/2003WO2003039564A1 Selective targeting of apoptotic cells
05/15/2003WO2003039563A1 Treatment and prevention of paresthesia comprising co-therapy with anticonvulsant derivatives and potassium
05/15/2003WO2003039562A1 Composition and method
05/15/2003WO2003039535A1 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
05/15/2003WO2002083926A3 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
05/15/2003WO2001080832A3 Administration of a thiol-based chemoprotectant compound
05/15/2003US20030093143 Medical device having surface depressions containing nitric oxide releasing compound
05/15/2003US20030092675 Skin treatment using a new retinoid
05/15/2003US20030092638 Protopanaxadiol and protopanaxatriol and their use as anti-cancer agents
05/15/2003US20030092636 Treatment and prevention of paresthesia comprising co-therapy with anticonvulsant derivatives and potassium
05/15/2003US20030091655 Method of administering high-dose, oral magnesium for treatment of chronic pain syndrome or erythromelalgia
05/15/2003US20030091654 Dietetics, antidiabetic agents; using chromium complex
05/15/2003US20030091644 Low concentration of peroxide for treating or preventing vaginal infections
05/15/2003US20030091630 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
05/15/2003US20030091621 Encapsulated drugs
05/15/2003US20030091607 Wrinkle resistance; cosmetics
05/15/2003US20030091574 Combination treatment of pancreatic cancer
05/15/2003US20030091561 Anticancer agents
05/15/2003US20030089618 Reducing electrolyzed water and method for producing same
05/15/2003CA2466303A1 Selective targeting of apoptotic cells
05/15/2003CA2466278A1 Rehydrating formulation
05/15/2003CA2465952A1 Treatment and prevention of paresthesia comprising co-therapy with anticonvulsant derivatives and potassium
05/15/2003CA2465862A1 Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
05/15/2003CA2462502A1 Improved use of antitumoral compound in cancer therapy
05/15/2003CA2462158A1 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
05/14/2003EP1309640A1 Polyurethane film-forming dispersions in alcohol-water system
05/14/2003EP1309627A1 Immunotherapy for chronic myelocytic leukemia
05/14/2003EP1309326A1 A therapeutic agent of osteoporosis comprising an active ingredient of quercetin derivatives
05/14/2003EP1309314A2 Method of making tablets and tablet compositions produced therefrom
05/14/2003EP1309309A1 Dermatological composition
05/14/2003EP1309251A1 Selenium diet supplement
05/14/2003EP0982996B1 Stable glycerin iodine concentrate compositions
05/14/2003EP0819006B1 Preparation of sodium chloride aerosol formulations
05/14/2003EP0814817B1 Use of sodium chloride for treating acne and/or rosacea
05/14/2003CN1416882A Burn treating Chinese medicine liquid and its prepn
05/14/2003CN1416859A Externally applied Chinese medicine with functions of diminishing inflammation, promoting granulation, stopping itch and stopping pain and its prepn process
05/14/2003CN1416840A Alopecia treating tincture and its prepn
1 ... 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 ... 563